Unibest
← Back to patent-cliff list

CAS 42518-98-9

5-chlorothiophene-2-carbonyl chloride

Codes: RIVA-013

Application context (from source-drug indications)

Pulmonary embolismRivaroxabanStrokeRivaroxabanCongenital heart defectRivaroxabanThrombosisRivaroxabanVenous thromboembolismRivaroxabanCoronary artery diseaseRivaroxaban

Source drugs (routes using this intermediate)

DrugTierExpiry
RivaroxabanTier A — Act now2026

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

RivaroxabanOptimised routesteps: 5total yield: 3.34 g

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Qualified Partner — East China API Works5-Chlorothiophene-2-carbonyl chloride
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.